Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
The University of Arizona Health Sciences
Tucson, Arizona
Credit Types: | CME |
Credit Amount: | 1.0 Credits |
Release Date: | 2017-Oct-13 |
Expiration Date: | 2018-Oct-12 |
Estimated Time for Completion: | 1 hour |
Registration Required: | No |
Cost: | Free of charge |
In this activity, a renowned expert in asthma discusses the role of targeted treatment in the management of patients with severe asthma.
Upon completion of this activity, participants should be better able to:
This activity has been designed to meet the educational needs of allergists, immunologists, pulmonologists, internal medicine physicians, and other clinicians involved in the treatment of patients with asthma.
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Enduring Material
Release and Expiration Dates: October 13, 2017 - October 12, 2018
Time to Complete: 60 minutes
In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Eugene R. Bleecker, MD
Co-Director of the Division of Pharmacogenomics
Co-Chief, Division of Genetics, Genomics and Precision Medicine
The University of Arizona Health Sciences
Tucson, Arizona
Eugene R. Bleecker, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from AsthmaNET; National Institutes of Health (NIH); Pharmacogenetics; SARP Pharmaceuticals PVT. LTD; and Spiromics. AstraZeneca-MedImmune; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./F. Hoffmann-La Roche Ltd; GlaxoSmithKline; Johnson & Johnson Services, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; sanofi-aventis/Regeneron Pharmaceuticals, Inc.; and Teva Pharmaceuticals for clinical trials administered through Wake Forest School of Medicine and/or the University of Arizona.
Speakers Bureau participant with AstraZeneca-MedImmune; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./F. Hoffmann-La Roche Ltd; GlaxoSmithKline; Knopp Biosciences LLC; Novartis Pharmaceuticals Corporation; sanofi-aventis/Regeneron Pharmaceuticals, Inc.; and Vectura Group plc.
Kate Nelson, PhD
PVI, PeerView Institute for Medical Education
Kate Nelson, PhD, has no financial interests/relationships or affiliations in relation to this activity.
Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.
Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G6168-18-T.
This CME activity is jointly provided by Penn State College of Medicine and PVI, PeerView Institute for Medical Education.
This educational activity is supported by an educational grant from GlaxoSmithKline.
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.
Copyright © 2000-2017, PeerView Press
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.